Clinical trials
Terminated Metabolic Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 4 |
| 2008 | 9 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 7 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Massachusetts General Hospital | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Queen's University | 2 |
| AHS Cancer Control Alberta | 1 |
| Baltimore VA Medical Center | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Beth Israel Medical Center | 1 |
| Boston Children's Hospital | 1 |
| Boston University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 69 |
| Obesity | 21 |
| Insulin Resistance | 10 |
| Diabetes Mellitus | 5 |
| Dyslipidemias | 5 |
| Hypertension | 5 |
| Overweight | 5 |
| Schizophrenia | 5 |
| Inflammation | 4 |
| Bipolar Disorder | 3 |
Trials
Showing 76 to 69 of 69. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.